Photodynamic therapy using endogenous photosensitization for gastrointestinal tumors

Yale Journal of Biology and Medicine

Volumn 70, Issue 1, 1997, Pages 127-137

  Webber, John ^a   Kessel, David ^a   Fromm, David ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN;

CELL DEATH; CONFERENCE PAPER; EARLY DIAGNOSIS; GASTROINTESTINAL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION;

EID: 0031471924     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (99)

1. Wilson, J.H.P., Van Hillegersberg, R., and Van Den Berg, J.W.O., et al. Photodynamic therapy for gastrointestinal tumors. Scand. J. Gastroenterol. 26(Suppl 188):20-25, 1991.
2. Konig, K., Wabnitz, H., Dietel, W. Variation in the fluorescence decay properties of hematoporphyrin derivative during its conversion into photoproducts. J. Photochem. Photobiol. B:Biol 8:103-111, 1990.
3. Weishaupt, K.R., Gomer, C.J., and Dougherty, T.J. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res. 36:2326-2329, 1976.
4. Foote, C.S. Mechanisms of photosensitized oxidation. Science 162:963-970, 1968.
5. Dougherty, T.J., Grindey, G.B., Fiel, R., et al. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J. Natl. Canc. Inst. 55:115-121.
6. Moan, J., Pettersen, E.O., and Christensen, T. The mechanism of photodynamic inactivation of human cells in vitro in the presence of hematoporphyrin. Br. J. Canc. 39:398-407, 1979.
7. Fromm, D., Kessel, D., and Webber, J. Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. Arch. Surg. 131:667-669, 1996.
8. Regula, J., MacRobert, A.J., Gorchein, A., et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study. Gut 36:67-75, 1995.
9. Kennedy, J.C., Pettier, R.H., and Pross, D.C. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J. Photochem. Photobiol. B:Biol 6:143-148, 1990.
10. Herrera-Ornelas, L., Petrelli, N.J., Mittelman, A., et al. Photodynamic therapy in patients with colorectal cancer. Cancer 57:677-684, 1986.
11. Evrard, S., Aprahamian, M., and Marescaux, J. Intra-abdominal photodynamic therapy: from theory to feasibility. Br. J. Surg. 80:298-303, 1993.
12. Grant, W.E., Hopper, C., MacRobert, A.J., Speight, P.M., and Brown, S.G. Photodynamic therapy of oral cancer: photosensitization with systemic aminolaevulinic acid. Lancet 342:147-148, 1993.
13. DeLaney, T.F., Sindelar, W.F., Tochner, Z., et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int. J. Rad. Oncol. Biol. Phys. 25:445-457, 1993.
14. Sindelar, W.F., DeLaney, T.F., Tochner, Z., et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Arch. Surg. 126:318-324, 1991.
15. Edell, E.S. and Cortese, D.A. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 102:1319-1322, 1992.
16. Pass, H.I., DeLaney, T.F, Tochner, Z., et al. Intrapleural photodynamic therapy: Results of a phase I trial. Ann. Surg. Oncol. 1:28-37, 1994.
17. Nambisan, R.N., Karakousis, C.P., Holyoke, E.D., and Dougherty, T.J. Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer 61:1248-1251, 1988.
18. Dougherty, T.J., Kaufman, J.E., Goldfarb, A., et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 38:2628-2635, 1978.
19. Benson, R.C., Jr. The use of hematoporphyrin derivative (Hpd) in the localization and treatment of transitional cell carcinoma (TCC) of the bladder. In: Doiron, D.R. and Gomer, C.J., eds. Porphyrin localization and treatment of tumors. New York: Alan R. Liss, 1984; pp. 795-804.
20. Sutedja, T., Kwa, B., van Kamp, H., and van Zandwijk, N. Photodynamic therapy as an alternative treatment for surgery in a patient with lung cancer undergoing bone marrow transplantation. Chest 103:1908-1909, 1993.
21. McCaughan, J.D., Nims, T.A., Guy, J.T., et al. Photodynamic therapy for esophageal tumors. Arch. Surg. 124:74-80, 1989.
22. Schoenfeld, N., Mamet, R., Nordenberg, Y., et al. Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: Characterization of photodynamic inactivation. Int. J. Canc. 56:106-112, 1994.
23. Imamura, S., Kusunoki, Y., Takifuji, N., et al. Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer. Cancer 73:1608-1614, 1994.
24. Gossner, L., Hahn, E.G., and Ell, C. Oral administration of 5-aminolaevulinic acid for photodynamic therapy in patients with gastrointestinal carcinomas: preliminary results. Gastroenterol. 106(abstract):387,1994.
25. Bedwell, J., MacRobert, A.J., Phillips, D., and Brown, S.G. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br. J. Canc. 65:818-824, 1992.
26. Rebeiz, N., Rebeiz, C.C., Arkins, S., Kelley, K.W., and Reibez, C.A. Photodestruction of tumor cells by induction of endogenous accumulation of protoporphyrin IX: enhancement by 1,10-phenathroline. Photochem. Photobiol. 55:431-435, 1992.
27. Kennedy, J.C. and Pottier, R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B: Biol 14:275-292, 1992.
28. Peng, O., Moan, J., Warloe, T., Nesland, J.M., and Rimington, C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int. J. Canc. 52:433-443, 1992.
29. Van Hillegersberg, R., Van Den Berg, J.W.O., Kort, W.J., et al. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterol. 103:647-551, 1992.
30. El-Sharabasy, M.M.H., El-Waseef, A.M., Hafez, M.M., and Salim, S.A. Porphyrin metabolism in some malignant diseases. Br. J. Canc. 65:409-412, 1992.
31. Daily, H.A., and Smith, A. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem. J. 223:441-445, 1986.
32. Schoenfeld, N., Epstein, O., Lahav, M., et al. The heme biosynthetic pathway in lymphocytes of patients with malignant proliferative disorders. Canc. Lett. 43:43-48, 1991.
33. Leibovici, L., Schoenfeld, N., Yehoshua, H.A., et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer. Cancer 62:2297-2300, 1988.
34. Lahav, M., Epstein, O., Schoenfeld, N., et al. Increased porphobilinogen deaminase activity in patients with malignant lymphoproliferative disease. JAMA 257:39-42, 1987.
35. Navone, N.M., Polo, C.F., Frisardi, A.L., et al. Heme biosynthesis in human breast cancer-mimetic "in vitro" studies and some heme enzymatic activity levels. Int. J. Biochem. 22:1407-1411, 1990.
36. Sima, A.A.F., Kennedy, J.C., Blakeslee, D., and Robertson, D.M. Experimental porphyric neuropathy: a preliminary report. Can. J. Neurol. Sci. 8:105-114, 1981.
37. Cincotta, L., Foley, J.W., MacEachern, T., et al. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas. Canc. Res. 54:1249-1258, 1994.
38. Truscott, T.G., McLean, A.J., Phillips, A.M.R., and Foulds, W.S. Detection of haematoporphyrin derivative and hematoporphyrin excited states in cell environments. Canc. Lett. 41:31-45, 1980.
39. Vasvari, G., Elzemzam, S., and Gal, D. Physico-chemical modeling of the role of free radicals in photodynamic therapy. II. Interactions of ground state senstizers with free radicals studied by chemiluminescence spectrometry. Biochem. Biophys. Res. Comm. 197:1536-1542, 1993.
40. Spikes, J.D. and Straight, R. Sensitized photochemical processes in biological systems. Ann. Rev. Phys. Chem. 18:409-436, 1967.
41. Spikes, J.D. Photochemotherapy: molecular and cellular processes involved. Advances Photochemotherapy, Proc. SPIE 997:92-100, 1988.
42. Ortel, B., Tanew, A., and Honigsmann, H. Lethal photosensitization by endogenous porphyrins of PAM cells - modification by desferrioxamine. J. Photochem. Photobiol. B: Biol 17:273-278, 1993.
43. Moan, J., and Berg, K. Photochemotherapy of cancer: Experimental research. Photochem. Photobiol. 55:931-948, 1992.
44. Henderson, B.W. and Dougherty, T.J. How does photodynamic therapy work? Photochem. Photobiol. 55:145-157, 1992.
45. Nseyo, U.O., Whalen, R.K., Duncan, M.R., et al. Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology 36:167-171, 1990.
46. Evans, S., Matthews, W., Perry, R., et al. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J. Natl. Canc. Inst. 82:34-39, 1990.
47. Moan, J. and Berg, K.. Photochemotherapy of cancer: experimental research. Photochem. Photobiol. 55:931-948, 1992.
48. Berg, K., Prydz, K., and Moan, J. Photochemical treatment with the lysosomally localized dye tetra(4-sulfonatophenyl)porphine results in lysosomal release of the dye but not of β-N-acetyl-D-glucosaminidase activity. Biochim. Biophys. Acta 1158:300-306, 1993.
49. Kessel, D. Sites of photosensitization by derivative of hematoporphyrin. Photochem. Photobiol. 44:489-494, 1986.
50. Agarwal, M.L., Clay, M.E., Harvey, E.J., et al. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51:5993-5996, 1991.
51. Gomer, C.J., Rucker, N., Ferrario, A., and Wong, S. Properties and applications of photodynamic therapy. Radiat. Res. 120:1-18, 1989.
52. Gomer, C.J., Luna, M., Ferrario, A., and Rucker, N. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic therapy or Photofrin incubation. Photochem. Photobiol. 53:275-279, 1991.
53. Gomer, C.J., Ferrario, A., Rucker, N., et al. Glucose regulated protein (GRP-78) induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res. 51:6574-6579, 1991.
54. 2, induction reduces haematoporphyrin-derivative-induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro. Biochem. J. 292:237-240, 1993.
55. 2 from cells by photodynamic treatment in vitro. Cancer Res. 49:6896-6900, 1989.
56. Webber, J., Luo, Y., Crilly, R., Fromm, D., and Kessel, D. An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. J. Photochem. Photobiol. B: Biol. 35:209-211, 1996.
57. Luna, M.C., Wong, S., and Gomer, C.J. Photodynamic therapy mediated induction of early response genes. Cancer Res. 54:1374-1380, 1994.
58. Weiman, T.J., Mang, T.S., Fingar, V.H., et al. Effect of photodynamic therapy on blood flow in normal and tumor vessels. Surgery 104:512-517, 1988.
59. Selman, S.H., Keck, R.W., Klaunig, J.E., et al. Acute blood flow changes in transplantable FANFT-induced urothelial tumors treated with hematoporphyrin derivative and light. Surg. Forum 34:676-678, 1983.
60. Star, W.M., Marijnissen, H.P.A., van den Berg-Blok, A.E., et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46:2532-2540, 1986.
61. Henderson, B.W. and Fingar, V.H. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem. Photobiol. 49:299-304, 1989.
62. van Geel, I.P.J., Oppelaar, H., Oussoren, Y.G., and Stewart, F.A. Changes in perfusion of mouse tumours after photodynamic therapy. Int. J. Canc. 56:224-228, 1994.
63. Thomlinson, R.H. and Gray, L.H. The histological structure of some human lung cancers and the possible implication for radiotherapy. Br. J. Canc. 9:539-549, 1955.
64. Loh, C.S., Bedwell, J., MacRobert, A.J., et al. Photodynamic therapy of normal rat stomach: a comparative study between di-sulfonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br. J. Canc. 66:452-462, 1992.
65. 2H NMR spectroscopy. NMR Biomed. 3:64-70, 1990.
66. West, C.M.L., West, D.C., Kumar, S., and Moore, J.V. A comparison of the sensitivity to photodynamic treatment of endothelial and tumour cells in different proliferative states. Int. J. Radiat. Biol. 58:145-156, 1990.
67. Leunig, M., Goetz, A.E., Gamarra, F., et al. Photodynamic therapy-induced alterations in interstitial fluid pressure, volume and water content of an amelanotic melanoma in the hamster. Br. J. Canc. 69:101-103, 1994.
68. Roberts, D.J.H., Cairnduff, F., Driver, I., et al. Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolaevulinic acid. Int. J. Oncol. 5:763-768, 1994.
69. Roberts, D.J.H., Cairnduff, F., Driver, I., Dixon, B., and, Bown, S.B. Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolevululinic acid. Int. J. Oncol. 5:763-768, 1994.
70. Bremner, J.C.M., Bradley, J.K., Stratford, I.J., and Adams, G.E. Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy. Br. J. Canc. 69:1083-1087, 1994.
71. Moan, J., and Sommer, S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res. 46:1608-1610, 1985.
72. Barr, H., Tralau, C.J., MacRobert, A.J., et al. Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Br. J. Canc. 56:111-118, 1987.
73. Potter, W.R., Mang, T.S., and Dougherty, T.J. The theory of photodynamic therapy dosimetry: consequences of photodestruction of sensitizer. Photochem. Photobiol. 46:97-101, 1987.
74. Webber, J., Kessel, D., and Fromm, D. Unpublished obervations.
75. Loh, C.S., MacRobert, A.J., Bedwell, J., et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br. J. Canc. 68:41-51, 1993.
76. 14C]-hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res. 39:146-151, 1979.
77. DeLaney, T.F., Sindelar, W.F., Tochner, Z., et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int. J. Rad. Oncol. Biol. Phys. 25:445-457, 1993.
78. Barr, H., Bown, S.G., Krasner, N., and Boulos, PB. Photodynamic therapy for colorectal disease. Int. J. Colored. Dis. 4:15-19, 1989.
79. Doiron, D.R., Svaasand, L.O., and Profio, A.E. Light dosimetry in tissue: application to photoradiation therapy. In: Advances in Experimental Medicine and Biology. Kessel, D. and Dougherty, T.J., eds. Plenum Press, New York. 160:63-77, 1983.
80. Kato, H., Kawaguchi, M., Konaka, C., et al. Evaluation of photodynamic therapy in gastric cancer. Lasers in Med. Sci. 1:67-74, 1986.
81. Sliney, D.H. and Trokel, S.L. Medical lasers and their safe use. Springer-Verlag; New York, 1992.
82. Profio, A.E. and Doiron, D.R. Dosimetry considerations in phototherapy. Med. Physics 8:190-196, 1981.
83. Svaasand, L.O. and Ellingsen, R. Optical penetration in human intracranial tumors. Photochem. Photobiol. 41:73-76, 1985.
84. Henderson, B.W. and Finger, V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47:3110-3114, 1987.
85. Moan, J. Effect of bleaching of porphyrin sensitizers during photodynamic therapy. Cancer Lett. 33:45-53, 1986.
86. Bown, S.G., Tralau, C.J., Coleridge-Smith, P.D., et al. Photodynamic therapy with porphyrin and phthalocyanine sensitisation in normal rat liver. Br. J. Canc. 54:43-52, 1986.
87. Svaasand, L.O. Thermal and optical dosimetry for photoradiation therapy of malignant tumors. In:Porphyrins in tumor phototherapy. Andreoni, A. and Cubeddu, R., (eds). Plenum Press, New York, pp. 261-279, 1984.
88. Ferrario, A. and Gomer, C.J. Systemic toxicity in mice induced by localized porphyrin photodynamic therapy. Cancer Res. 50:539-543, 1990.
89. Gibson, S.L., Foster, T.H., Feins, R.H., et al. Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br. J. Canc. 69:473-481, 1994.
90. Foster, T.H. and Gao, L. Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density. Radiat. Res. 130:379-383, 1992.
91. Sibille, A., Lambert, R., Souquet, J.-C., et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterol. 108:337-344, 1995.
92. Abulafi, A.M. and Williams, N.S. Photodynamic therapy for cancer: Still awaiting rigorous evaluation. BMJ 304:589-900, 1992.
93. van Gemert, J.C., Berenbaum, M.C., and Gijsbers, G.H.M. Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative. Br. J. Canc. 52:43-49, 1985.
94. Barr, H., Krasner, N., Boulous, P.B., et al. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br. J. Surg. 77:93-96, 1990.
95. Roberts, W.G., Smith, K.M., McCullough, J.L., and Berns, M.W. Skin photosensitivity and photodestruction of several photodynamic sensitizers. Photochem. Photobiol. 49:431-438, 1989.
96. Foultier, M.-T., Vonarx-Coinsman, V., de Brito, L.X., et al. DNA or cell kinetics flow cytometry analysis of 33 small gastrointestinal cancers treated by photodynamic therapy. Cancer 73:1595-1607, 1994.
97. Stein, J.A., Crul, F.D., Valsamis, M., and Tschudy, D.P. Abnormal iron and water metabolism in acute intermittent porphyria with new morphologic findings. Am. J. Med. 53:784-789, 1972.
98. Kennedy, J. HPD photoradiation therapy for cancer at Kingston and Hamilton. Porphyrin Photosensitization. Plenum Publishing Corp. pp. 53-62, 1983.
99. Goff, B.A., Bachor, R., Kollias, N., and Hasan, T. Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. J. Photochem. Photobiol. B:Biol 15: 239-251, 1992.